Agios Pharmaceuticals (AGIO) Change in Inventory (2018 - 2026)

Agios Pharmaceuticals' Change in Inventory history runs 8 years deep, the most recent figure standing at $2.2 million for Q1 2026.

• Quarterly Change in Inventory rose 8.95% year-over-year to $2.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.5 million (down 16.11% YoY) and the FY2025 annual result came in at $5.3 million, down 37.89% from the prior year.
• Change in Inventory was $2.2 million for Q1 2026 at Agios Pharmaceuticals, up from $886000.0 in the prior quarter.
• Across five years, Change in Inventory topped out at $4.3 million in Q2 2023 and bottomed at $867000.0 in Q2 2024.
• A 5-year average of $2.1 million and a median of $1.8 million in 2023 frame the typical range for Change in Inventory.
• Annual changes were most pronounced in 2023 — Change in Inventory surged 172.83% — and 2024, when it plunged 79.82%.
• Agios Pharmaceuticals' Change in Inventory stood at $3.3 million in 2022, then plunged by 45.66% to $1.8 million in 2023, then tumbled by 34.13% to $1.2 million in 2024, then dropped by 25.36% to $886000.0 in 2025, then soared by 144.58% to $2.2 million in 2026.
• Business Quant data shows AGIO's Change in Inventory at $2.2 million in Q1 2026, $886000.0 in Q4 2025, and $1.2 million in Q3 2025.